Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Nature Protocols
|
September 1, 2017
Optimized retroviral transduction of mouse T cells for in vivo assessment of gene function
Makoto Kurachi, Junko Kurachi, Zeyu Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 19, 2017
The Loss of TET2 Promotes CD8<sup>+</sup> T Cell Memory Differentiation
Shannon A Carty, Mercy Gohil, Lauren B Banks, et al.
Nature Immunology
|
April 23, 2013
The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling
Donald T Gracias, Erietta Stelekati, Jennifer L Hope, et al.
Cancer Immunology, Immunotherapy : CII
|
June 23, 2025
Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
Nilesh U Deshpande, Anna Bianchi, Haleh Amirian, et al.
Cell Reports
|
May 17, 2018
Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155
Erietta Stelekati, Zeyu Chen, Sasikanth Manne, et al.
Nature Immunology
|
July 27, 2021
Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation
Mohamed S Abdel-Hakeem, Sasikanth Manne, Jean-Christophe Beltra, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 20, 2016
Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells
Martin S Naradikian, Arpita Myles, Daniel P Beiting, et al.
Immunity
|
May 20, 2014
Bystander chronic infection negatively impacts development of CD8(+) T cell memory
Erietta Stelekati, Haina Shin, Travis A Doering, et al.
Frontiers in Immunology
|
January 24, 2018
The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8<sup>+</sup> T Cells <i>via</i> SHIP-1
Jennifer L Hope, Christopher J Stairiker, Panagiota I Spantidea, et al.
Oncoimmunology
|
October 6, 2018
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
David L Bajor, Rosemarie Mick, Matthew J Riese, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Nature Protocols
|
September 1, 2017
Optimized retroviral transduction of mouse T cells for in vivo assessment of gene function
Makoto Kurachi, Junko Kurachi, Zeyu Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 19, 2017
The Loss of TET2 Promotes CD8<sup>+</sup> T Cell Memory Differentiation
Shannon A Carty, Mercy Gohil, Lauren B Banks, et al.
Nature Immunology
|
April 23, 2013
The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling
Donald T Gracias, Erietta Stelekati, Jennifer L Hope, et al.
Cancer Immunology, Immunotherapy : CII
|
June 23, 2025
Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
Nilesh U Deshpande, Anna Bianchi, Haleh Amirian, et al.
Cell Reports
|
May 17, 2018
Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155
Erietta Stelekati, Zeyu Chen, Sasikanth Manne, et al.
Nature Immunology
|
July 27, 2021
Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation
Mohamed S Abdel-Hakeem, Sasikanth Manne, Jean-Christophe Beltra, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 20, 2016
Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells
Martin S Naradikian, Arpita Myles, Daniel P Beiting, et al.
Immunity
|
May 20, 2014
Bystander chronic infection negatively impacts development of CD8(+) T cell memory
Erietta Stelekati, Haina Shin, Travis A Doering, et al.
Frontiers in Immunology
|
January 24, 2018
The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8<sup>+</sup> T Cells <i>via</i> SHIP-1
Jennifer L Hope, Christopher J Stairiker, Panagiota I Spantidea, et al.
Oncoimmunology
|
October 6, 2018
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
David L Bajor, Rosemarie Mick, Matthew J Riese, et al.
Page
of 3